-
1.发明授权公开(公告)号：US08785034B2
公开(公告)日：2014-07-22
申请号：US13300732
申请日：2011-11-21
申请人： Magdalena Forster , Katharina Schmut , Bernhard Goller , Guenter Zieger , Michael Sorger , Philemon Schweizer , Michael Sternad
发明人： Magdalena Forster , Katharina Schmut , Bernhard Goller , Guenter Zieger , Michael Sorger , Philemon Schweizer , Michael Sternad
IPC分类号： H01M10/052 , H01L23/48
CPC分类号： H01M10/0525 , H01L27/06 , H01L2224/48091 , H01L2224/48472 , H01L2924/1461 , H01M4/386 , H01M4/66 , H01M4/70 , H01M6/40 , H01M10/0436 , H01M10/049 , H01M10/052 , H01M10/0585 , H01M10/425 , H01M2220/30 , H01M2250/30 , Y02B90/18 , Y02E60/122 , Y02P70/54 , Y10T29/49108 , Y10T29/49115 , H01L2924/00014 , H01L2924/00
摘要： A lithium battery includes a cathode, an anode including a component made of silicon, a separator element disposed between the cathode and the anode, an electrolyte, and a substrate. The anode is disposed over the substrate or the anode is integrally formed with the substrate.
摘要翻译： 锂电池包括阴极，包括由硅制成的部件的阳极，设置在阴极和阳极之间的隔膜元件，电解质和基板。 阳极设置在衬底上，或者阳极与衬底一体地形成。
-
2.发明申请公开(公告)号：US20130128488A1
公开(公告)日：2013-05-23
申请号：US13300732
申请日：2011-11-21
申请人： Magdalena Forster , Katharina Schmut , Bernhard Goller , Guenter Zieger , Michael Sorger , Philemon Schweizer , Michael Sternad
发明人： Magdalena Forster , Katharina Schmut , Bernhard Goller , Guenter Zieger , Michael Sorger , Philemon Schweizer , Michael Sternad
CPC分类号： H01M10/0525 , H01L27/06 , H01L2224/48091 , H01L2224/48472 , H01L2924/1461 , H01M4/386 , H01M4/66 , H01M4/70 , H01M6/40 , H01M10/0436 , H01M10/049 , H01M10/052 , H01M10/0585 , H01M10/425 , H01M2220/30 , H01M2250/30 , Y02B90/18 , Y02E60/122 , Y02P70/54 , Y10T29/49108 , Y10T29/49115 , H01L2924/00014 , H01L2924/00
摘要： A lithium battery includes a cathode, an anode including a component made of silicon, a separator element disposed between the cathode and the anode, an electrolyte, and a substrate. The anode is disposed over the substrate or the anode is integrally formed with the substrate.
摘要翻译： 锂电池包括阴极，包括由硅制成的部件的阳极，设置在阴极和阳极之间的隔膜元件，电解质和基板。 阳极设置在衬底上，或者阳极与衬底一体地形成。
-
3.发明授权公开(公告)号：US07202081B2
公开(公告)日：2007-04-10
申请号：US10776733
申请日：2004-02-11
申请人： Bernhard Goller , Manfred Kubbies
发明人： Bernhard Goller , Manfred Kubbies
IPC分类号： C12N5/00
CPC分类号： G01N33/5011 , G01N33/5014
摘要： A method for the simultaneous determination of cell proliferation inhibition activity and cell toxicity (induction of cell death) of a substance using a proliferating mammalian cell sample as a test system.
摘要翻译： 使用增殖性哺乳动物细胞样品作为测试系统同时测定物质的细胞增殖抑制活性和细胞毒性（诱导细胞死亡）的方法。
-
公开(公告)号：US20060089359A1
公开(公告)日：2006-04-27
申请号：US11233311
申请日：2005-09-23
申请人： Edward Boyd , Frederick Brookfield , Guy Georges , Bernhard Goller , Sabine Huensch , Petra Rueger , Matthias Rueth , Stefan Scheiblich , Christine Schuell , Wolfgang von der Saal , Justin Warne , Stefan Weigand
发明人： Edward Boyd , Frederick Brookfield , Guy Georges , Bernhard Goller , Sabine Huensch , Petra Rueger , Matthias Rueth , Stefan Scheiblich , Christine Schuell , Wolfgang von der Saal , Justin Warne , Stefan Weigand
IPC分类号： A61K31/502 , C07D403/02
CPC分类号： C07D403/12
摘要： Compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates are disclosed. Also disclosed are methods for the preparation of the above-mentioned compounds, pharmaceutical compositions containing them, as well as the use of the above-mentioned compounds in the treatment, control or prevention of illnesses such as cancer.
摘要翻译： 公开了式I化合物的药学上可接受的盐，对映体形式，非对映异构体和外消旋体。 还公开了制备上述化合物的方法，含有它们的药物组合物，以及上述化合物在治疗，控制或预防诸如癌症等疾病中的用途。
-
5.发明授权Amphotropic retrovirus packaging cell line, process for its production and use thereof 有权大片逆转录病毒包装细胞系，其生产和使用过程公开(公告)号：US06475786B1
公开(公告)日：2002-11-05
申请号：US09700979
申请日：2001-06-11
IPC分类号： C12N500
CPC分类号： C12N7/00 , C12N15/86 , C12N2740/13052
摘要： A titer of retroviral vectors of at least about 107 colony-forming units/ml cell culture supernatants is obtained using an amphotropic retroviral packaging cell line which contains functional gag, pol and env genes integrated into the genome in which the expression of the genes gag and pol is regulated independently of the expression of the env genes, wherein the genome of the said cell line contains one or two functionally active env genes.
摘要翻译： 使用包含功能性gag，pol和env基因整合到基因组中的功能性gag，pol和env基因，获得至少约107个菌落形成单位/ ml细胞培养上清的逆转录病毒载体的滴度，其中基因gag和 pol独立于env基因的表达调节，其中所述细胞系的基因组含有一个或两个功能活性的env基因。
-
公开(公告)号：US07462639B2
公开(公告)日：2008-12-09
申请号：US11384052
申请日：2006-03-17
申请人： Guy Georges , Bernhard Goller , Klaus-Peter Kuenkele , Aude Lemarchand , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth
发明人： Guy Georges , Bernhard Goller , Klaus-Peter Kuenkele , Aude Lemarchand , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth
IPC分类号： A61K31/4155 , C07D487/04
CPC分类号： C07D487/04
摘要： The present invention relates to the compounds of formula I: their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing them and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明涉及式I化合物：其药学上可接受的盐或酯，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物组合物及其制备，以及这些化合物的用途 控制或预防癌症等疾病。
-
公开(公告)号：US07285569B2
公开(公告)日：2007-10-23
申请号：US11233408
申请日：2005-09-23
申请人： Georges Guy , Bernhard Goller , Hans-Willi Krell , Klaus-Peter Kuenkele , Anja Limberg , Petra Rueger , Matthias Rueth
发明人： Georges Guy , Bernhard Goller , Hans-Willi Krell , Klaus-Peter Kuenkele , Anja Limberg , Petra Rueger , Matthias Rueth
IPC分类号： A61K31/4184 , A61K31/4155 , C07D487/02 , C07D403/04
CPC分类号： A61K31/4184 , C07D487/04 , C07D487/10
摘要： The present invention relates to compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明涉及式I化合物的药学上可接受的盐，对映体形式，非对映异构体和外消旋体，上述化合物的制备，含有它们的药物及其制备，以及上述化合物在 控制或预防癌症等疾病。
-
公开(公告)号：US20060142247A1
公开(公告)日：2006-06-29
申请号：US11301993
申请日：2005-12-13
申请人： Guy Georges , Bernhard Goller , Klaus-Peter Kuenkele , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth , Christine Schuell
发明人： Guy Georges , Bernhard Goller , Klaus-Peter Kuenkele , Anja Limberg , Ulrike Reiff , Petra Rueger , Matthias Rueth , Christine Schuell
IPC分类号： C07F7/02 , A61K31/695 , A61K31/675 , C07D471/02
CPC分类号： C07D487/04 , C07D471/04
摘要： The present invention relates to the compounds of formula I their pharmaceutically acceptable salts or esters, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, pharmaceutical compositions containing such compounds and their manufacture, as well as the use of such compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明涉及式I化合物其药学上可接受的盐或酯，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有这些化合物的药物组合物及其制备方法以及这些化合物的用途 控制或预防癌症等疾病。
-
9.发明申请SUBSTITUTED INDAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 审中-公开取代的吲哚衍生物，其制造和用作药物代理公开(公告)号：US20090291968A1
公开(公告)日：2009-11-26
申请号：US12293428
申请日：2007-03-21
申请人： Guy Georges , Bernhard Goller , Anja Limberg , Petra Rueger , Matthias Rueth , Christine Schuell , Mark Stahl
发明人： Guy Georges , Bernhard Goller , Anja Limberg , Petra Rueger , Matthias Rueth , Christine Schuell , Mark Stahl
IPC分类号： A61K31/4188 , C07D487/04 , A61K31/4196 , A61K31/4439 , A61K31/506
CPC分类号： C07D487/04
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物 控制或预防癌症等疾病。
-
10.发明申请PHTHALAZINONE PYRAZOLE DERIVATIVES, THEIR MANUFACTURE AND USE AS PHARMACEUTICAL AGENTS 审中-公开苯并噻唑酮衍生物及其制备方法及用作药物代理公开(公告)号：US20090221599A1
公开(公告)日：2009-09-03
申请号：US12279894
申请日：2007-03-16
申请人： Edward Boyd , Frederick Brookfield , Steve Courtney , Guy Georges , Bernhard Goller , Anja Limberg , Michael Prime , Petra Rueger , Matthias Rueth
发明人： Edward Boyd , Frederick Brookfield , Steve Courtney , Guy Georges , Bernhard Goller , Anja Limberg , Michael Prime , Petra Rueger , Matthias Rueth
IPC分类号： A61K31/501 , C07D403/12
CPC分类号： C07D403/12 , C07D401/14
摘要： Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.
摘要翻译： 本发明的目的是式I化合物，其药学上可接受的盐，对映体形式，非对映异构体和外消旋物，上述化合物的制备，含有它们的药物及其制备，以及上述化合物 控制或预防癌症等疾病。
-
-
-
-
-
-
-
-
-
搜索结果
16 条记录 (耗时 0.021 秒)
